Abstract
The importance of the adrenergic system in the electrical activity of the heart can be briefly summarized by stating that the endogeneous catecholamines liberated by sympathetic excitation may substantially affect those electrophysiologic parameters of the heart which have been shown to play a significant role in the regulation of cardiac rate and rhythm and in the genesis of cardiac arrhythmias. Increased tone of the sympathetic nervous system as well as administration of catecholamines or other sympathomimetic agents closely resembling in structure the naturally occurring adrenergic activators may produce a variety of arrhythmias, from simple extrasystoles to lethal ventricular fibrillation. If the concentration of the adrenergic activators is high enough as in the case of pheochromocytoma, neuroblastoma, or overdosage of these agents, this may alone account for their arrhythmogenic action. On the other hand sensitivity to catecholamines can also be increased as in hyperthyroidism or when some hydrocarbon anesthetics are applied. Sometimes other potentially arrhythmogenic situations such as hypoxia of the heart, local myocardial ischemia due to coronary occlusion, ionic changes, (e.g., hypo- or hyperpotassemia) and high level of free fatty acids may produce manifest arrhythmias, if the cardiac sympathetic tone is increased or adrenergic activators are given. Since the term “cardiac arrhythmia” denotes the irregular activity of the whole cardiac syncitium, none of the electrophysiologic effects alone, even the most impressing changes determined by intracellular recordings or membrane current measurements, can account directly for the arrhythmic action of the adrenergic activators.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ahlquist, R.P.: A study of the adrenotropic receptors. Am. J. Physiol. 153, 586–600 (1948)
Ahlquist, R.P.: The adrenotropic receptor-detector. Arch. Int. Pharmacodyn. Ther. 139, 38–41 (1962)
Ahlquist, R.P.: Present state of alpha- and beta-adrenergic drugs. I. The adrenergic receptor. Am. Heart J. 92, 661–664 (1976a)
Ahlquist, R.P.: Present state of alpha- and beta-adrenergic drugs. II. The adrenergic blocking agents. Am Heart J. 92, 804–807 (1976 b)
Ahlquist, R.:.: Present state of alpha- and beta-adrenergic drugs. III. Beta blocking agents. Am. Heart J. 93, 117–120 (1977)
Allen, C.R., Stutzman, H.W., Meek, W.J.: The production of ventricular tachycardia by adrenaline in cyclopropane anesthesia. Anesthesiology 1, 158–166 (1940)
Allen, J.D., Zaidi, S.A., Shanks, R.G., Pantridge, J.F.: The effects of bretylium on experimental cardiac arrhythmias. Am. J. Cardiol. 29, 641–649 (1972)
Andersen, N., Johansen, S.H.: Incidence of catechol-amine-induced arrhythmias during halothane anesthesia. Anesthesiology 24, 51–56 (1963)
Angelakos, E.T.: Regional distribution of catecholamines in the dog heart. Circ. Res. 16, 39–44 (1965)
Angelakos, E.T., Daniels, J.B.: Effect of catecholamine infusion on lethal hypothemic temperatures in dogs. J. Appl. Physiol. 26, 194–196 (1969)
Angelakos, E.T., Torchiana, M.L.: Adrenergic factors in cardiac arrhythmias. In: Cardiac Arrhythmias. Dreifus, L.S., Likoff, W. (eds.), pp. 505–517. New York, London: Grune & Stratton 1973 )
Angelakos, E.T., Fuxe, K., Torchiana, M.L.: Chemical and histochemical evaluation of the distribution of catecholamines in the rabbit and guinea pig hearts. Acta Physiol. Scand. 59, 184–192 (1963)
Angelakos, E.T., King, M.P., Millard, R.W.: Regional distribution of catecholamines in the heart of various species. Xnn. N.Y. Acad. Sci. 156, 219–240 (1969 a)
Angelakos, E.T., Mäher, J.T., Burlington, R.F.: Spontaneous cardiac activity at low temperatures in hibernators and non-hibernators: Influence of potassium and catecholamines. Fed. Prod. 28, 1216–1219 (1969b)
Angelucci, L., Lorentz, G., Baldieri, M.: The relation between noradrenaline content of rabbit heart muscle and the amount of K-Strophanthin needed to produce arrhythmias. J. Pharm. Pharmacol. 18, 775–782 (1966 b)
Anitschkow, S.V.: Über die Wirkung der vago- und sympathikotropen Gifte auf verschiedene Herzknoten. Naunyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmakol. 177, 260–271 (1935)
Antalóczy, Z.: Intracardiac pathomechanism of the development of cardiac dysrhythmias. Magy. Belorv. Arch. 16, 228–235 (1963)
Antalóczy, Z., Erdelyi, A.: Significance of acetylcholine and catecholamines in the genesis of cardiac arrhythmias. Magy. Belorv. Arch. 17, 270–276 (1964)
Antoni, H.: Electrophysiological mechanisms underlying pharmacological models of cardiac fibrillation. Naunyn-Schmiedeberg’s Arch. Pharmacol. 269, 177–199 (1971)
Antoni, H., Zerweck, T.: Besitzen die sympathischen Überträgerstoffe einen direkten Einfluß auf die Leitungsgeschwindigkeit des Säugetiermyokards? Pflügers Arch. ges. Physiol. 293, 310–330 (1967)
Antoni, J.A., Srinivas, H.V.: Clinical evaluation of phentolamine in cardiac arrhythmias. Indian Heart J. 24, 25–30 (1972)
Ariëns, E.J.: Wirkung und Wirkungsmechanismus von Katecholaminen und ihre Derivaten. Naunyn-Schmiedeberg’s Arch. exp. Pathol. Pharmakol. 257, 118–141 (1967)
Arora, R.B.: Antiarrhythmics, quinidine-like activity of some ataraxic agents. J. Pharmacol. Exp. Ther. 124, 53–58 (1958)
Arora, B.B., Madan, B.R.: Antiarrhythmic action of the minor and major tranquillizers. Pharmacol. Ther. 4, 633–656 (1979)
Bacaner, M.: Bretylium tosylate for suppression of induced ventricular fibrillation. Am. J. Cardiol. 17, 528–534 (1966)
Bacaner, M.: Quantitative comparison of bretylium with other antifibrillatory drugs. Am. J. Cardiol. 21, 504–512 (1968 a)
Bacaner, M., Schreinemachers, D.: Bretylium tosylate for suppression of ventricular fibrillation after experimental myocardial infarction. Nature 220, 494–496 (1968 b)
Bacaner, M.: Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. Am. J. Cardiol. 21, 530–543 (1968 b)
Bacaner, M., Schreinemachers, D.: Antifibrillatory property of bretylium in relation to its effect on recovery of cardiac excitability. Fed. Proc. 26, 444 (1967)
Bagwell, E.E., Hilliard, C.C., Daniell, H.B., Taylor, P.L., Walton, R.P.: Studies on the inotropic mechanism of phentolamine. Am. J. Cardiol. 25, 83 (1970)
Barrett, A.M.: A comparison of the effects of (±)-propranolol and (+)-propranolol in anesthetized dogs, β-reeeptor blocking and hemodynamic action. J. Pharm. Pharmacol. 21, 241–247 (1969)
Bassett, A.L., Wit, A.L.: Recent advances in electrophysiology of antiarrhythmic drugs. Prog. Drug. Res. 17, 33–58 (1973)
Baugh, C.W., Cornett, R.W., Hatcher, J.D.: The adrenal gland and the cardiovascular changes in acute anoxic anoxia in dogs. Circ. Res. 7, 513–520 (1959)
Beck, C.S.: Asphyxiated heart and ventricular fibrillation. Letters to the Editor. Am. J. Physiol. 199, 1245 (1960)
Bendikov, A.E.: Effect produced by amizyl, iprazid and nitroglycerin upon the coronary circulation with experimentally induced spasms of the cardiac vessels. Farmakol. Toksikol. 27, 695–699 (1964)
Benfey, B.G., Varma, D.R.: Interactions of sympathomimetic drugs propranolol and phentolamine, on atrial refractory period and contractility. Br. J. Pharmacol. 30, 603–611 (1967)
Bennett, C.R., Smookler, H.H., Buckley, J.P.: Prevention of ventricular fibrillation during induced hypothermia by N,N-diisopropyl-N’-soamyl-N’-diethylaminoethylurea (P-286) Pharm. Exp. Ther. 159, 115–122 (1968)
Berkowitz, W.D., Wit, A.L., Lau, S.H., Steiner, C., Damato, A.N.: Effects of propranolol on cardiac conduction. Circulation 40, 855–862 (1969)
Berne, R.M.: The effect of immersion hypothermia on coronary blood flow. Circ. Res. 2, 236–242 (1954)
Bigger, T.J., Jaffe, C.C.: The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers. Am. J. Cardiol. 27, 82–92 (1971)
Birnbaum, L., Weiner, A., Farah, A.: Mechanisms in the production of atrial fibrillation during asphyxia. Am. Heart J. 63, 676–687 (1962)
Black, W.L., Rolett, E.L.: Cardiovascular alpha-adrenergic properties of dopamine (P). Circulation 32, 11–51 1965
Black, W.L., Rolett, E.L.: Dopamine-induced alterations in left ventricular performance. Circ. Res. 19, 71–79 (1966)
Black, J.W., Stephenson, J.S.: Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet 2, 311–314 (1962)
Blazsovszky, M., Papp, Gy., Szekeres, L.: Cardiac electrophysiological effects of arrhythmogenic agents and antiarrhythmic drugs in experimental hyperthyroidism. Abstracts of 3 th Hungarian Pharmacological Meeting, Debrecen, 1977. p. 62
Blinks, J.R.: The nature of the antagonism by methoxamine of the chronotropic and inotropic effects of catecholamines. Naunyn-Schmiedeberg’s Arch. exp. Pathol. Pharmakol. 2 248, 73–84 (1964)
Boger, D.C., Leveque, P.E.: The antiarrhythmic effect of (–) N-(l-phenylethyl) guanidine. Arch. Int. Pharmacodyn. Ther. 175, 129–135 (1968)
Boineau, J.P., Cox, J.L.: Slow ventricular activation in acute myocardial infarction. A source of re-entrant premature ventricular contractions. Circulation 48, 702–711 (1973)
Borbola, J., Papp, J.Gy., Szekeres, L.: Interaction of free fatty acids and catecholamines on the electrical activity of cardiac muscle and Purkinje fibers. Naunyn-Schmiedeberg’s Arch. Pharmacol. 285, R 5 (1974)
Borbola, J., Papp, J.Gy., Szekeres, L.: Effects of free fatty acids on the automaticity of the sinus node and Purkinje fibers. In: Symposium on Pharmacology of the Heart. Szekeres, L., Papp, J.Gy. (eds.), pp. 75–80. Budapest: Akademiai Kiadó 1976 a
Borbola, J., Papp, J.Gy., Szekeres, L.: Microelectrophysiological alterations in blood superfused canine Purkinje fibers induced by metoprolol and quinidine. Abstracts of the 6 th Yugoslav Pharmacological Meeting, Ljubljana, 1976 (b), p. 49
Borbola, J., Papp, J.Gy., Szekeres, L.: Experimental study of the supposed arrhythmogenic effect of high free fatty acid level in acute myocardial infarction. Lecture held on the Congress of Hungarian Cardiological Society, Balatonfüred, 1977. p. 39
Borbola, J., Papp, J.Gy., Szekeres, L.: Method for studying the microelectrophysiological properties of the isolated Purkinje fiber superfused extracorporally with blood from a donor animal. Cardiol. Hung. 6, 1–11 (1977)
Borbola, J., jr., Papp, J.Gy., Szekeres, L.: Influence of free fatty acids on the cardiac effects of catecholamines. Acta Physiol. Acad. Sci. Hung. 48, 168 (1976)
Boura, A.L.A., Green, A.F.: Adrenergic neuron blockade and other acute effects caused by N- benzyl-N’N-dimethylguanidine and its orthochloro derivative. Br. J. Pharmacol. 20, 36–62 (1963)
Brill, I.C., Krueger, J.D., McCawley, E.L.: Restoration of sinus rhythm in experimental and clinical ventricular arrhythmias by methoxamine hydrochloride. Am. J. Cardiol. 3, 307–313 (1959)
Brooks, C.McC., Hoffman, B.F., Suckling, E.E., Orias, O.: Excitability of the heart. New York: Grune & Stratton 1955
Brown, T.G. jr., Cotten, J. de V.: Evaluation of factors enhancing cardiac force during hypothermia. Fed. Proc. 15, 405 (1956)
Burgess, M.J., Abildskov, J.A., Millar, K., Geddes, J.S., Green, L.S.: Time course of vulnerability to fibrallation after experimental coronary occlusion. Am. J. Cardiol. 27, 617–621 (1971)
Cardinal, R., Sasynivk, B.I.: Electrophysiological effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts: J. Pharmacol. Exp. Ther. 204, 159–174 (1978)
Carpentier, R., Vassalle, M.: Restoration of electrical activity of guinea pig atria during hypothermia. Effects of norepinephrine and electrical stimulation on membrane potentials. Circ. Res. 31, 507–519 (1972)
Carmeliet, E., Vereeke, J.: Adrenaline and the plateau phase of the cardiac action potential. Pflügers Arch. 313, 300–315 (1969)
Ceremuzynski, L., Staszewska-Barczak, J., Herbaczynska-Cedro, K.: Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc. Res. 3, 190–197 (1969)
Chalmers, J.P., Isbiter, J.P., Korner, P.I., Mok, H.Y.I.: The role of the sympathetic nervous system in the circulatory response of the rabbit to arterial hypoxia. J. Physiol. (Lond.) 181, 175–191 (1965)
Chatterjee, K., Parmley, W.W., Ganz, W., Torrester, J., Walinsky, P., Crexells, C., Swan, H.J.C.: Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48, 1183–1193 (1973)
Chenoweth, M.B.: Ventricular fibrillation induced by hydrocarbons and epinephrine. J. Industr. Hyg. 28, 151–158 (1946)
Clark, E.R., Hughes, I.E.: Blocking action of some quaternary derivatives of 2-/2,6-xylyloxy/ ethylamine on adrenergic nerves. Br. J. Pharmacol. 28, 105–127 (1966)
Coltart, D.J., Meldrum, S.J.: The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential. Arch. Int. Pharmacodyn. Ther. 192, 188–197 (1971)
Cookson, B.A., Neptune, W.B., Baily, C.D.: Hypothermia as means of performing intracardiac surgery under direct vision. Dis. Chest 22, 245–260 (1952)
Covino, B.G.: Antifibrillary effect of mephentermine sulfate /Wyamin/1 in general hypothermia. J. Pharmacol. Exp. Ther. 122, 418–422 (1958)
Covino, B.G., D’Amato, H.L.: Mechanism of ventricular fibrillation in hypothermia. Circ. Res. 10, 148–155 (1962)
Covino, B.G., Charleson, D.A., D’Amato, H.E.: Ventricular fibrillation in the hypothermic dog. Am. J. Physiol. 178, 148–154 (1954)
Cranefield, P.F.: The conduction of the cardiac impulse: The slow response and cardiac arrhythmias. New York: Futura 1975
Cranefield, P.F., Hoffman, B.F., Wit, A.L.: Block of conduction in partially depolarized cardiac Purkinje fibers induced by an alpha-adrenergic agent. Nature /New Biol./ 234, 159–160 (1971)
Csik, V., Szekeres, L, Takats, I., Udvary, É.: Analysis of the effect of adrenergic beta blockade in a new experimental model of angina pectoris. In: Symposium of pharmacology of the heart. Szekeres, L., Papp, J.Gy. (eds.), pp. 239–246. Budapest: Akadémiai Kiadó 1976
Dahlstrom, A., Fuxe, K., Mya-Tu, M., Zetterstrom, B.E.M.: Observations on adrenergic innervation of dog heart. Am. J. Physiol. 209, 689–692 (1965)
Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A., Udenfriend, S.: Effect of the blockers on catecholamine biosynthesis. Fed. Proc. 27, 240 (1968)
Davis, L.D., Temte, J.V.: Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers in the dog. Circ. Res. 22, 661–667 (1968)
DeGeest, H., Levy, M.N., Zieske, H.: Chemoreceptor stimulation and ventricular performance. Am. J. Physiol. 209, 564–570 (1965 a)
DeGeest, H., Levy, M.N., Zieske, H.: The reflex effects of cephalic hypoxia, hypercapnia, and ischemia upon ventricular contractility. Circ. Res. 17, 349–358 (1965 b)
Dhingra, R.C., Winslow, E., Pouget, J.M., Rahimtoola, S.G., Rosen, K.M.: Effect of isoproterenol on atrioventricular and intraventricular conduction. Am. J. Cardiol. 32, 629–636 (1973)
Dóda, M., György, L., Kenyeres, J., Nádor, K.: The pulse rate-reducing and anti-arrhythmic effects of N-4-cyclohexylbenzyl-3 -benzoyl-granatanium bromide. Acta Physiol. Acad. Sci. Hung. 34, 107–115 (1968)
Downing, S.E., Siegel, J.H.: Baroreceptor and chemoreceptor influences on sympathetic discharge to the heart. Am. J. Physiol. 204, 471–479 (1963)
Downing, S.E., Mitchell, J.H., Wallace, A.W.: Cardiovascular responses to ischemia and hypercapnia of the central nervous system. Am. J. Physiol. 204, 881–887 (1963)
Dreifus, L.S., Watanabe, Y., Dreifus, H.N., Azavedo, I.: The effect of antiarrhythmic agents on impulse formation and impulse conduction. In: The conduction system of the heart. Wellens, H.J.J., Lie, K.I., Janse, M.J. (eds.), Chap. 10, p. 182. Leiden: Stenfert Kroese 1976
Dresel, P.E., Duncan, D.G.: Induction of automaticity in cat papillary muscles by sympathomimetic amines. J. Pharmacol. Exp. Ther. 133, 70–75 (1961)
Dresel, P.E., MacCannell, K.L., Nickerson, M.: Cardiac arrhythmia induced by minimal doses of epinephrine in cyclopropane-anesthetized dogs. Circ. Res. 8, 948–955 (I960)
D’Silva, J.L.: Action of adrenaline on serum potassium. J. Physiol. (Lond.) 90, 303–309 (1937)
Dutta, S.N., Booker, W.M.: Possible myocardial adaptation to acute coronary occlusion: Relation to catecholamines. Arch. Int. Pharmacodyn. Ther. 185, 5–12 (1970)
Ebert, P.A., Vanderbeek, R.B., Allgood, R.J., Sabiston, D.C.: Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation. Cardiovasc. Res. 4, 141–147 (1970)
Eichbaum, F.B., Gazetta, B.H., Bissetti, P.C., Pereira, C.B.: Electrocardiographic disturbances following acute increase of intracranial pressure. Z. ges. exp. Med. 139, 721–734 (1965)
Elio, F.J.: Action of acetylcholine, adrenaline and other substances on refractory period of rabbit auricle. Br. J. Pharmacol. 2, 131–142 (1947)
Ellis, C.H.: Control of ventricular tachycardias in dogs by B.W. 62-235, a derivative of methoxamine. Arch. Int. Pharmacodyn. Ther. 150, 144–155 (1964)
Emiroglu, F.: Fibrillation of normothermic and hypothermic rabbit heart and effect of adrenaline. Arch. Int. Physiol. 73, 55–64 (1965)
Erdélyi, A., Gyárfás, I.: Disturbances of cardiac rhythm caused by acetylcholine and catecholamines in animals with complete heart block. Acta Med. Acad. Sci. Hung. 21, 325–335 (1965)
Erlij, D., Mendez, C.: Adrenergic actions on heart rate, atrioventricular refractory period and intraventricular conduction in dogs. Arch. Int. Physiol. 72, 44–65 (1964)
Ettinger, S., Gould, L., Carmichael, J.A., Tashjian, R.J.: Phentolamine use in digitalis induced arrhythmias. Am. Heart J. 77, 636–640 (1969)
Falck, B., Nielsen, K.C., Owman, Ch., Persson, H., Sporrong, B.: Adrenergic mechanisms in the development of hypothermic ventricular fibrillation in the isolated perfused heart of the cat. Eur. J. Pharmacol. 17, 66–74 (1972)
Farmer, J.B.: Indirect sympathomimetic actions of dopamine. J. Pharm. Pharmacol. 18, 261–262 (1966)
Fastier, F.N., Smirk, F.H.: Some properties of amarin, with special reference to its use in con-junction with adrenaline for the production of idio-ventricular rhythms. J. Physiol. (Lond.) 107, 318–331 (1948)
Fawaz, G.: The mechanism by wich N:N-dibenzyl-chloroethylamine protects animals against cardiac arrhythmias induced by sympathomimetic amines in presence of cyclopropane or chloroform. Br. J. Pharmacol. 6, 492–498 (1951)
Fisher, E.R., Fischer, B., Fedor, E.J.: Nor-epinephrine cells of adrenal medulla following hypothermia and unilateral adrenolectomy. Proc. Exp. Biol. Med. 89, 140–142 (1955)
Fitzgerald, J.D., O’Donnell, S.R.: A comparison of the hemodynamic effects of propranolol, 4 hydroxypropranolol and practolol in anesthetized dogs. Br. J. Pharmacol. 45, 207–217 (1972)
Fleming, W.W.: Supersensitivity of the cat heart to catecholamine induced arrhythmias following reserpine pretreatment. Proc. Soc. Exp. Biol. Med. 111, 484–486 (1962)
Foldi, M., Solti, F.: Hypoxic ECG produced experimentally by isolated cerebral hypoxia in the dog. Magy. Tud. Akad. Biol. Orv. Tud. Oszt. Közl. 8, 427–430 (1958)
Garb, S., Chenoweth, M.B.: Studies on hydrocarbon-epinephrine induced ventricular fibrillation. J. Pharmacol. Exp. Ther. 94, 12–18 (1948)
Gardier, W.G., Abren, B.D., Richards, A.B., Herrlich, H.C.: Specific blockade of the adrenal medulla. J. Pharmacol. Exp. Ther. 130, 340–345 (1960)
Geesbreght, J.M., Randall, W.G.: Area localization of shifting cardiac pacemakers during sympathetic stimulation. Am. J. Physiol. 220, 1522–1527 (1971)
Gibson, D., Sowton, E.: The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog. Cardiovasc. Dis. 12, 16–39 (1969)
Gilbert, J.L., Lange, G.G., Plevoy, I., Brooks, C.McC.: Effects of vasoconstrictor agents on cardiac irritability. J. Pharmacol. Exp. Ther. 123, 9–15 (1958)
Gilbert, J.L., Lange, G.G., McBrooks, V.: Influence of sympathomimetic pressor drugs on arrhythmias caused by multiple stimuli. Circ. Res. 7, 417–423 (1959)
Gillis, C.N., Paton, D.M.: Effects of hypothermia and anoxia on retention of noradrenaline by the cat perfused heart. Br. J. Pharmacol. 26, 426–434 (1966)
Gilmore, M.S., Siegel, J.H.: Mechanism of the myocardial effects of bretylium. Circ. Res. 10, 347–353 (1962)
Giotti, A., Ledda, F., Mannaioni, P.F.: Electrophysiological effects of alpha and beta-receptors agonists and antagonists on Purkinje fibres of sheep heart. Br. J. Pharmacol. 34, 695P–696P (1968)
Giotti, A., Ledda, F., Mannaioni, P.F.: Effects of noradrenaline and isoprenaline in combination with alpha and beta-receptor blocking substances on the action potential of cardiac Purkinje fibers. J. Physiol. (Lond.) 229, 99–113 (1973)
Glassman, J.M., Seifer, J.: The effect of mephentermine on hypodynamic and arrhythmic isolated frog hearts. J. Pharmacol. Exp. Ther. 112, 364–373 (1954)
Glick, G., Planth, W.H. jr., Braunwald, E.: Circulatory response to hypoxia in unanesthetized dogs with and without cardiac denervation. Am. J. Physiol. 207, 753–758 (1964)
Goldberg, L.: Effects of hypothermia on contractility of the intact dog heart. Am. J. Physiol. 194, 92–99 (1958)
Goldreyer, B.N., Bigger,.J.T. jr.: Site of reentry in paroxysmal supraventricular tachycardia in man. Circulation 43, 15–26 (1971)
Goldstein, M., Nakajima, K.: The effect of disulfiram on the biosynthesis of catecholamines during exposure of cats to cold. Life Sci. 5, 175–179 (1966)
Gould, L.: Phentolamine. Am. Heart J. 78, 276–278 (1969)
Gould, L.: Phentolamine. Am. Heart J. 92, 397–402 (1976)
Gould, L.: Electrophysiological properties of phentolamine in man. Br. Heart J. 39, 939–944 (1977)
Gould, L., Zahir, M., Shariff, M., Giuliani, M.G.: Treatment of cardiac arrhythmias with phentolamine. Am. Heart J. 78, 189–193 (1969)
Gould, L., Umali, F., Colinbarranco, M., Gomprecht, R.F.: Control of supraventricular premature beat with phentolamine. J. Clin. Pharmacol. 12, 356–361 (1972)
Gould, L., Reddy, C.V.R., Kalanithi, D., Espina, L., Gomprecht, R.F.: Use of phentolamine in acute myocardial infarction. Am. Heart J. 88, 144–148 (1974 a)
Gould, L., Reddy, C.V.R., Gomprecht, R.F.: The effect of phentolamine on atrioventricular conduction in man. Chest. 65, 158–162 (1974b)
Gould, L., Reddy, C.V.R., Blatt, C.J., Gomprecht, R.F., Hayt, D.B.: Phentolamine, effects on coronary blood flow in humans with recent myocardial infarction. Br. Heart J. 37, 647–651 (1975 a)
Gould, L., Reddy, C.V.R., Weinstein, T., Gomprecht, R.F.: Antiarrhythmic prophylaxis with phentolamine in acute myocardial infarction. J. Clin. Pharmacol. 15, 191–197 (1975 b)
Govier, W.C.: Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents. J. Pharmacol. Exp. Ther. 159, 82–90 (1968)
Govier, W.C., Mosal, N.C., Whittington, P., Broom, A.H.: Myocardial alpha and beta adrenergic receptors as demonstrated by atrial functional refractory-period changes. J. Pharmacol. Exp. Ther. 154, 255–263 (1966)
Göpfert, H.: Zur Frage des Kreislaufreflexes bei Erstickung und Sauerstoffmangel. Pflügers Arch. ges. Physiol. 249, 209–229 (1947)
Greenfield, L.J., Ebert, P.F.: Cardiac denervation effect in hypoxia and hypercapnia. Effect of total denervation on cardiovascular responses. Arch. Surg. 87, 717–721 (1963)
Grisk, A., Scheler, W., Kraatz, G.: Katecholamingehalt und flimmerwidrige Wirkung einiger Antiarrhythmika. Acta Biol. Med. Ger. 16, 54–60 (1966)
Haas, H.G.: Active ion transport in heart muscle. In: Electrical phenomena in the heart. De- Mello, W.C. (ed.). New York: Academic Press 1972
Han, J., Garcia de Jalon, P.D., Moe, G.K.: Adrenergic effects on ventricular vulnerability. Circ. Res. 14, 516–524 (1964)
Han, J., Moe, G.K.: Nonuniform recovery of excitability in ventricular muscles. Circ. Res. 14, 44–60 (1964)
Harris, A.S., Matlock, P.W.: The effects of anoxemic anoxia on excitability, conduction and refractoriness. Am. J. Physiol. 149, 493–503 (1947)
Harris, A.S., Otero, H., Bocage, A.J.: The induction of arrhythmias by sympathetic activity before and after occlusion of a coronary artery in the canine heart. J. Electrocardiol. 4, 34–43 (1971)
Hashimoto, K., Hauswirth, O., Wehner, H.D., Ziskoven, R.: The relation between the current underlying pacemaker activity and beta-adrenoceptors in cardiac Purkinje fibres. Naunyn- Schmiedeberg’s Arch. Pharmacol. 307, 9–19 (1979)
Hauswirth, O., Singh, B.N.: Voltage clamp in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol. Rev. 30, 5–63 (1979)
Hauswirth, O., Noble, D., Tsien, R.W.: Adrenaline: Mechanism of action on the pacemaker potential in cardiac Purkinje fibers. Science 162„ 916–917 (1968)
Hauswirth, O., Wehner, H.D., Ziskoven, R.: Alpha-adrenergic receptors and pacemaker current in cardiac Purkinje fibers. Nature 263, 155–156 (1976)
Hayashi, K.D., Moss, A.J., Yu, P.N.: Urinary catecholamine excretion in myocardial infarction. Circulation 40, 473–481 (1969)
Herman, Z.S., Petelenz, T.: The effect of serotonin on the electrocardiogram in pigeons. Acta Physiol. Pol. 15, 269–278 (1964)
Hermansen, K.: Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists. Br. J. Pharmacol. 35, 476–486 (1969)
Hermansen, K.: Evidence for adrenergic mediation of ouabain-induced arrhythmias in the guinea pig. Acta Pharmacol. Toxicol. (Kbh.) 28, 57–65 (1970)
Hertting, G., Axelrod, J., Patrick, R.W.: Actions of bretylium and guanethidine on the uptake and release of /3H/ noradrenaline. Br. J. Pharmacol. 18, 161–166 (1962)
Hey, P., Willey, G.L.: Choline 2:6-xylyl ether bromide: an active quaternary local anaesthetic. Br. J. Pharmacol. 9, 471–475 (1954)
Hoff, H.E., Nahum, L.H.: The role of adrenaline in the production of ventricular rhythms and their suppression by acetyl-β-methylcholine chloride. J. Pharmacol. Exp. Ther. 52, 235–245 (1934)
Hoffman, B.F.: Hypothermia and vulnerability. Ann. N.Y. Acad. Sci. 80, 348–350 (1959)
Hoffman, B.F.: The electrophysiology of the heart muscle and the genesis of arrhythmias. In: Mechanism and therapy of cardiac arrhythmias. Dreifus, L.S., Hikoff, W.L., (eds.), p. 27. New York, London: Grune & Stratton 1966 a
Hoffman, B.F.: The genesis of cardiac arrhythmias. Prog. Cardiovasc. Dis. 8, 319–329 (1966 b)
Hoffman, B.F.: The possible mode of action of antiarrhythmic agents. In: The myocardial cell- structure, function and modification by cardiac drugs. Briller, S.A., Conn, H.L. jr. (eds.), p. 251. Philadelphia: University of Pennsylvania Press 1966 c
Hoffman, B.F., Cranefield, P.F.: Electrophysiology of the heart. New York: McGraw-Hill 1960
Hoffman, B.F., Cranefield, P.F.: Paired-pulse stimulation of the heart. Am. Heart J. 71, 143–150 (1966)
Hoffman, B.F., Singer, D.H.: Appraisal of the effects of catecholamines on cardiac electrical activity. Ann. N.Y. Acad. Sci. 139, 914–939 (1967)
Hoffman, B.F., Siebens, A. A., Cranefield, P.F., Brooks, McC.C.: The effect of epinephrine and norepinephrine on ventricular vulnerability. Circ. Res. 3, 140–146 (1955)
Holder, D.A., Sniderman, A.D., Fraser, G., Fallen, E.L.: Experience with bretylium tosylate by a hospital cardiac arrest team. Circulation 55, 541–544 (1977)
Holmes, J.C., Fowler, N.O.: Direct cardiac effects of dopamine. Circ. Res. 10, 68–72 (1962)
Huang, T.F.: Studies on prevention and abolition of fibrillation of the cat’s heart by drugs. Arch. Int. Pharmacodyn. Ther. 141, 239–253 (1963)
Hume, D.M., Edgahl, R.H.: Effect of hypothermia and of cold exposure on adrenal cortical and medullary secretion. Ann. N.Y. Acad. Sci. 80, 435–444 (1959)
Hume, D.M., Edgahl, R.H., Nelson, D.H.: In: The physiology of induced hypothermia. Dripps, R.D. (ed.), Vol. 451, p. 170. Washington: National Academy of Sciences, National Research Council 1956 Cit.: Bigelow, W.G., Sidloishy, S.: Hormones in hypothermia. Br. Med. Bull. 17, 56 (1956)
Hutter, O.F., Trautwein, W.: Vagal and sympathetic effects on pacemaker fibers in sinus venosus of heart. J. Gen. Physiol. 39, 715–733 (1956)
Ide, M.: Effect of acute hypothermia upon the noradrenaline and adrenaline content of the adrenal gland in the cat. Tohoku J. Exp. Med. 73, 70–73 (1960)
Imai, S.: Effects of methoxamine upon the membrane resting and action potentials of the guinea pig’s ventricular muscle fibres. Jpn. J. Physiol. 11, 54–61 (1961)
Imai, S., Shigei, T., Hashimoto, K.: Cardiac actions of methoxanine. With special reference to its antagonistic action to epinephrine. Circ. Res. 9, 552–560 (1961)
Jacob, J., Poite-Bevirre, M.: Actions de la sérotonine et de la benzyl-1 dimethyl-2,5 serotonine sur le coeur isole de lapin. Arch. Int. Pharmacodyn. Ther. 127, 11–26 (1960)
Jalavisto, E., Kantero, I., Leikola, Y.: The effect of methylene blue on the heart dying from anoxia. Acta Physiol. Scand. 23, 212–223 (1951)
Jequier, E., Perret, C.: Urinary excretion of catecholamines and their main metabolites after myocardial infarction: Relationship to the clinical syndrome. Eur. J. Clin. Invest. 1, 77–83 (1970)
Jewitt, D.E., Mercer, C.J., Reid, D., Valori, C., Thomas, M., Shillingfor, J.P.: Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet 1, 635–641 (1969)
Kabela, E., Mendez, R.: Action of propranolol on the atrioventricular node and on its response to adrenaline and isoprenaline. Br. J. Pharmacol. 26, 473–481 (1966)
Kahn, R.H.: Die Störungen der Herztätigkeit durch Adrenalin im Elektrokardiogramm. Pflügers Arch. ges. Physiol. 129, 379–401 (1909)
Kao, C.Y., Hoffman, B.F.: Graded and decremental responses in heart muscle fibers. Am. J. Physiol. 194, 187–193 (1958)
Karim, S.M.M.: Sympathetic beta-receptor blocking action of methoxamine. Br. J. Pharmacol. 24, 365–374 (1965)
Katz, A.M.: Physiology of the Heart. New York: Raven Press 1977
Katz, R.L.: Antiarrhytmic action of N,N- bis (phenylcarbamoylmethyl) dimethyl ammonium chloride (QX-572) in cat and dog. Anesthesiology 25, 291–296 (1964a)
Katz, R.L.: Antiarrhythmic and cardiovascular effects of synthetic oxytocin. Anesthesiology 25, 653–661 (1964b)
Katz, R.L.: Effects of alpha and beta adrenergic blocking agents on cyclopropane-catecholamine cardiac arrhythmias. Anesthesiology 26, 289–298 (1965)
Katz, R.L.: Neural factors affecting cardiac arrhythmias induced by halopropane. J. Pharmacol. Exp. Ther. 152, 88–94 (1966)
Katz, R.L., Lord, C.O., Eakins, K.E.: Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade. J. Pharmacol. Exp. Ther. 158, 40–45 (1967)
Kaye, M.P., Geesbreght, J.M., Randall, W.C.: Distribution of autonomic nerves to the canine heart. Am. J. Physiol. 218, 1025–1029 (1970)
Kelliher, G.J., Roberts, J.: Effect of 6-hydroxydopamine on ouabain-induced arrhythmia. Am. J. Cardiol. 31, 140 (1973)
Kelly, D.T., Delgado, C.E., Taxlor, D.R., Pitt, B., Ross, R.S.: Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation 47, 729–735 (1973)
Khan, A.H., Boughner, D.R., Haider, R.: Effect of phentolamine on atrioventricular conduction in man assesed by recording His bundle potential. Br. Heart J. 34, 1102–1106 (1972)
Khan, M.I., Hamilton, J.T., Manning, G.W.: Protective effect of beta adrenoceptors blockade in experimental coronary occlusion in conscious dogs. Am. J. Cardiol. 30, 832–837 (1972)
Klein, R.F., Troyer, W.G., Thompson, H.K., Bogdonoff, M.C., Wallace, A.G.: Catecholamine excretion in myocardial infarction. Arch. Intern. Med. 122, 476–482 (1968)
Koerpel, B.J., Davis, L.D.: Effects of lidocaine, propranolol and Sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers. Circ. Res. 30, 681–689 (1972)
Korner, P.I., Edwards, A.W.T.: The immediate effects of acute hypoxia on the heart rate, arterial pressure, cardiac output and ventillation of the unanaesthetized rabbit. Q. J. Exp. Physiol. 45, 113–122 (1960a)
Korner, P.I., Edwards, A.W.T.: The cardiac output during the steady-state in oxygen lack in the unanesthetized rabbit and its relation to the early circulatory response. Q. J. Exp. Physiol. 45, 129–141 (1960b)
Korner, P.I., Uther, J.B.: Dynamic characteristics of the cardiovascular autonomic effects during severe arterial hypoxia in the unanesthetized rabbit. Circ. Res. 24, 671–686 (1969)
Korner, P.I., White, S.W.: Circulating control in hypoxia by the sympathetic nerves and adrenal medulla. J. Physiol. 184, 272–290 (1966)
Kostrzewa, R.M., Jacobowitz, D.M.: Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199–288 (1974)
Krayer, O., Fuentes, J.: Changes of heart rate caused by direct cardiac action of reserpine. J. Pharmacol. Exp. Ther. 123, 145–152 (1958)
Kumakura, S., Somani, P.: The effects of LB-46 a β-adrenoceptor blocking drug on isolated normal and ouabain intoxicated Purkinje fibers of the dog. Eur. J. Pharmacol. 25, 335–350 (1974)
Kurien, V.A., Oliver, M.F.: Serum free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet 2, 122–127 (1966)
Kurien, V.A., Oliver, M.F.: Metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet 1, 813–816 (1970)
Kuschinsky, G.: Untersuchungen über sympatol, einen adrenalinàhnlichen Kòrper. Naunyn-Schmiedeberg’s Arch. Exp. Pathol. Pharmakol. 156, 290–308 (1930)
Kuschinsky, G., Lullmann, H., Peters, T.: Kurzes Lehrbuch der Pharmakologie und Toxikologie. Stuttgart: Thieme 1978
Lahti, R.E., Brill, J.C., McCawley, E.L.: The effect of methoxamine hydrochloride (Vasoxyl) on cardiac rhythm. J. Pharmacol. Exp. Ther. 115, 268–274 (1955)
Lands, A.M., Arnold, A., McAnliff, J.P.: Differentation of receptor systems activated by sympathomimetic amines. Nature 214, 597–598 (1967)
Langer, S.Z., Draskóczy, P.R., Trendelenburg, U.: Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J. Pharmacol. Exp. Ther. 157, 255–273 (1967)
Ledda, F., Marchetti, P.: Effects of phentolamine on transmembrane action potentials of single Purkinje fibers of sheep heart. Pharmacol. Res. Commun. 3, 155–164 (1971)
Lefkowitz, R.J.: Toward isolation of a β-adrenergic binding protein. In: Frontiers in catecholamine research. Snyder, U., Snyder, S. (eds.), p. 361. New York: Pergamon Press 1973
Leimdorfer, A.: Prevention and abolition of cardiac arrhythmias by regitine. Am. J. Physiol. 171, 742 (1952)
Leimdorfer, A.: Abolition of cardiac arrhythmias by regitine. Arch. Int. Pharmacodyn. Ther. 96, 249–256 (1953)
Lenel, R., Vanloo, A., Rodbard, S., Katz, L.N.: Factors involved in the production of paroxysmal ventricular tachycardia induced by epinephrine. Am. J. Physiol. 153, 553–557 (1948)
Leveque, P.E.: Guanethidine as an antifibrillatory agent. Nature 203, 1389 (1964 a)
Leveque, P.E.: A simple repeatable standardized procedure for the production of auricular fibrillation in the intact dog. Arch. Int. Pharmacodyn. Ther. 149, 297–307 (1964 b)
Leveque, P.E.: Anti-arrhythmic action of bretylium. Nature 207, 203–204 (1965)
Leveque, P.E.: Bethanidine: A new antifibrillatory agent. Arch. Int. Pharmacodyn. Ther. 163, 422–426 (1966)
Levy, A.G.: The genesis of ventricular extrasystoles under chloroform; with special reference to consecutive ventricular fibrillation. Heart 5, 299–344 (1914)
Lindner, E.: Untersuchungen iiber die flimmerwidrige Wirkung des N-/3’-phenylpropyl/-/27-1,1 -Diphenyl-propy1-/3/-500 (1963)
Lish, P.M., Weikel, J.H., Dungan, K.W.: Pharmacological and toxicological properties of two new β-adrenergic receptor antagonists. J. Pharmacol. Exp. Ther. 149, 161–173 (1965)
Lubbe, W.F., Bricknell, O.L., Podzuweit, T., Opie, L.H.: Cyclic AMP as a determinant of vulnerability to ventricular fibrillation in the isolated rat heart. Cardiovasc. Res. 10, 697–702 (1976)
Lubbe, W.F., Podzuweit, Th., Daries, P.S., Opie, L.H.: The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J. Clin. Invest. 62, 1260–1269 (1979)
Lucchesi, B.R., Hardman, H.F.: The influence of dichloroisoproterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias. J. Pharmacol. Exp. Ther. 132, 172–175 (1961)
Lucchesi, B.R., Whitsitt, L.S.: The pharmacology of beta-adrenergic blocking agents. Prog. Cardiovasc. Dis. 11, 410–430 (1969)
Lucchesi, B.R., Whitsitt, L.S., Stickney, J.L.: Antiarrhythmic effects of beta adrenergic blocking agents. Ann. N.Y. Acad. Sci. 139, 940–951 (1967)
Lynch, P.R., Webber, D.L., Oppenheimer, M.J.: Mephentermine as antifibrillatory drug against cyclopropane-epinephrine ventricular fibrillation. Anesthesiology 16, 632–642 (1955)
MacAlpin, R.N., Zalis, E.G., Kivowitz, C.F.: Prevention of recurrent ventricular tachycardia with oral bretylium tosylate. Ann. Intern. Med. 72, 909–912 (1970)
Maling, H.M., Moran, N.C.: Ventricular arrhythmias induced by sympathomimetic amines in unanesthetized dogs following coronary artery occlusion. Circ. Res. 5 409–413 (1957)
Malméjac, J., Malmejac, C., Laville, C., Margarit, J.: Action cardiaque de l’adrenaline en hypothermic profonde. C.R. Soc. Biol. (Paris) 157, 956–961 (1963)
Manning, J.W., Cotten, M.V.: Mechanism of cardiac arrhythmias induced by diencephalic stimulation. Am. J. Physiol. 203, 1120–1124 (1962)
Mathes, P., Gudbjarnason, S.: Changes in norepinephrine stores in the canine heart following experimental myocardial infarction. Am. Heart J. 81, 211–219 (1971)
Mathes, P., Gowan, C., Gudbjarnason, S.: Storage and metabolism of norepinephrine after experimental myocardial infarction. Am. J. Physiol. 220, 27–32 (1971)
McDonald, L., Baker, C., Bray, C., McDonald, A., Restieaux, N.: Plasma-catecholamines after cardiac infarction. Lancet 2, 1021–1023 (1969)
Meek, W.J.: Some cardiac effects of the inhalant anesthetics and the sympathomimetic amines. Harvey Lect. 1941
Meek, W.J., Hathaway, H.R., Orth, O.S.: The effects of ether, chloroform and cyclopropane on cardiac automaticity. J. Pharmacol. Exp. Ther. 61, 240–252 (1937)
Misu, Y., Nishio, H.: Action of guanethidine on rabbit atrial membranes. Br. J. Pharmacol. 63, 17–23 (1978)
Moe, G.K., Malton, S.D., Rennick, B.R., Freyburger, W.A.: The role of arterial pressure in the induction of idioventricular rhythms under cyclopropane anesthesia. J. Pharmacol. Exp. Ther. 94, 319–327 (1948)
Moore, J.I., Swain, H.H.: Sensitization to ventricular fibrillation. I. Sensitization by a substituted propiophenone, U-0882,2. J. Pharmacol. Exp. Ther. 128, 243–252 (1960 a)
Moore, J.I., Swain, H.H.: Sensitization to ventricular fibrillation. II. Sensitization by amarine and congeners of U-0882. J. Pharmacol. Exp. Ther. 128, 253–258 (1960 b)
Moran, N.C., Moore, J.I., Holcomb, H.K., Mushet, G.: Antagonism of adrenergically-induced cardiac arrhythmias by dichloroisoproterenol. J. Pharmacol. Exp. Ther. 136, 327–335 (1962)
Nagasawa, K., Vyden, J.K., Forrester, J., Corday, E.: Effect of phentolamine on cardiac performance and energetics in acute infarction. Circulation 48, Suppl. 4, 199 (1973)
Nahum, L.H., Hoff, H.E.: The mechanism of sudden death in experimental acute benzol poisoning. J. Pharmacol. Exp. Ther. 50, 336–345 (1934)
Narimatsu, A., Taira, N.: Positive dromotopic effect of dibutyryl cyclic adenosine 3’,5’-monophosphate on the atrioventricular node. Eur. J. Pharmacol. 42, 71–78 (1977)
Nickerson, M., Nomaguchi, G.: Mechanism of dibenamine protection against cyclopropane-epinephrine cardiac arrhythmias. J. Pharmacol. Exp. Ther. 95, 1–11 (1949)
Nielsen, K.C., Owman, C.: Control of ventricular hypothermia in cats. Life Sci. 5, 1611–1623 (1966)
Nielsen, K.C., Owman, C.: Control of ventricular fibrillation during induced hypothermia in cats after differential depletion of cardiac catecholamine stores with Prenylamine /Segontin/. Circ. Res. 21, 45–58 (1967 a)
Nielsen, K.C., Owman, C.: Differential amine depletion from cardiac adrenergic nerves by Segontin. Experientia 23, 203–204 (1967 b)
Nielsen, K.C., Owman, C.: Control of ventricular fibrillation during induced hypothermia in cats after blocking the adrenergic neurons with bretylium. Life Sci. 7, 159–168 (1968 a)
Nielsen, K.C., Owman, C.: Effect of reserpine on the spontaneous ventricular fibrillation developing during induced deep hypothermia in cats. Arch. Int. Pharmacodyn. Ther. 175, 412–421 (1968 b)
Nielsen, K.C., Owman, C., Rosengren, E.: Effect of cardiac catecholamine depletion through sympathectomy on spontaneous ventricular fibrillation during induced hypothemia in cats. Experientia 24, 1215–1217 (1968)
Nobel, E., Rothberger, C.J.: Z. ges. exp. Med. 3,151 (1914) Quotation from Szekeres, L., Papp, J.Gy.: Experimental cardiac arrhythmias and antiarrhythmic drugs. Budapest: Akademiai Kiadó 1971
Nye, C.E., Roberts, J.: The reactivity of atrial and ventricular pacemakers to quinidine. J. Pharmacol. Exp. Ther. 152, 67–74 (1966)
Oliver, M.F., Yates, P.A.: Induction of ventricular arrhythmias by elevation of arterial free fatty acids in experimental myocardial infarction. Cardiology 56, 359–364 (1972)
Papp, J.Gy.: Importance of the neurovegetative blocking action of antiarrhythmic drugs in cardiac arrhythmias of various origin. In: Proceedings of the IV th Hungarian Conference for Therapy and Pharmacological Research. Knoll, J. (ed.), pp. 217–223. Budapest: Akadémiai Kiadó 1966
Papp, J.Gy.: Data on the adrenergic mechanism and pharmacotherapy of cardiac rhythm disturbances. Thesis. Pécs 1967
Papp, J.Gy.: A study of the mode of action of some adrenergic beta-receptor blocking compounds. Thesis. Oxford 1969
Papp, J.Gy.: Analysis of the cardiac actions of pindolol (Visken) and other beta-adrenergic blocking agents. Cardiol. Hung. 2A, 1–26 (1973)
Papp, J.Gy. (Gen.Ed.): Research in Cardiovascular Pharmacology at the Department of Pharmacology, Szeged University of Medical Sciences, pp. 1–64. Szikra, Pécs 1977
Papp, J.Gy.: Médicaments anti-arythmiques. In: Thérapeutique médicale. Fabre, J. (ed.), Chap. 43, pp. 312–326. Paris: Flammarion 1978
Papp, J.Gy., Szekeres, L.: Acute effects of some biogenic amines and amine depleting agents on the tendency of the heart to arrhythmia. Acta physiol. Acad. Sei. Hung. 30, 334 (1966)
Papp, J.Gy., Szekeres, L.: Influence of the stretch and dynamic functional state of the myocardium on the tendency of the heart to arrhythmia. Acta Physiol. Acad. Sci. Hung. 32, 163–174 (1967 a)
Papp, J.Gy., Szekeres, L.: Die Wirkung von Sympathomimetika bei Herzrhythmusstörungen. Verhandlungen der Gesellschaft für experimentelle Medizin der Deutschen Demokratischen Republik. Vol. 12, p. 244. Dresden: Steinkopff 1967 b
Papp, J.Gy., Szekeres, L., Szmolenszky, T.: The effect of quanidine, ajmaline, papaverine and adrenergic β-receptor inhibitors in experimental BaCl2-arrhythmia developed for quantitative assay of anti-arrhythmic drugs. Acta Physiol. Acad. Sci. Hung. 32, 365 (1967 c)
Papp, J.Gy., Szekeres, L.: Analysis of the mechanism of adrenergic actions on ventricular vulnerability. Eur. J. Pharmacol. 3, 15–26 (1968 a)
Papp, J.Gy., Szekeres, L.: The arrhythmogenic action of sympathomimetic amines. Eur. J. Pharmacol. 3, 4–14 (1968 b)
Papp, J.Gy., Szekeres, L.: Antifibrillatory action of some adrenergic neuron blocking com- punds. Abstracts of the lectures of the IX th International Congress of Pharmacology, p. 276. Basel, 1969
Papp, J.Gy., Szekeres. L.: On the nature of adrenergic receptors involved in catecholamine-induced changes in the electrical activity of the heart. Dissert. Pharm. Pharmacol. 23, 622 (1971)
Papp, J.Gy., Szekeres, L.: The receptor mechanism of some cardio-electrophysiological effects of adrenergic excitants. Acta Physiol. Acad. Sci. Hung. 41, 339 (1972 a)
Papp, J.Gy., Szekeres, L.: Cardiac electrophysiological changes due to exyfedrine. In: Action of oxyfedrine. Gerlach, E., Moser, K., (eds.), pp. 3–13. Stuttgart, New York: Schattauer 1972b
Papp, J.Gy., Szekeres, L.: Adrenergic mechanisms in the genesis of cardiac dysrhythmias. In: Herzrhythmusstörungen. Antoni, H., Effert, S. (eds.), pp. 34–55. Stuttgart, New York: Schattauer 1974
Papp, J. Gy., Vaughan Williams, E.M.: The effect of intracellular atrial potentials of bretylium in relation to its local anaesthetic potency. Br. J. Pharmacol. 35, 352–353 (1969)
Papp, J.Gy., Förster, W., Szekeres, L, Rosier, V.: Action of β-receptor blocking sympatholytics and catecholamine depeting agents on CaCl2-induced arrhythmias in rats. Experientia 22, 524–525 (1966)
Pérez-Medina, T., Udvary,É., Csordás Nagy, É., Szekeres, L.: Responsiveness of the ischemic area to some agents. Abstracts of the 42 th Hungarian Physiological Meeting, Debrecen 1978, pp. 49–50
Podzuweit, T., Lübbe, W.F., Opie, L.H.: Cyclic adenosine monophosphate, ventricular fibrillation and antiarrhythmic drugs. Lancet 1, 341–342 (1976)
Poisner, A.M., Douglas, W.W.: The requirement for calcium in adrenomodullary secretion evoked by histamine, serotonin, angiotensin and bradykinin. Fed. Proc. 24, 488 (1965)
Powel, C.E., Slater, I.H.: Blocking of inhibitory adrenergic receptors by dichloro analog of isoproterenol. J. Pharmacol. Exp. Ther. 122, 480–488 (1958)
Priola, D.V.: Effects of beta receptor stimulation and blockade on A-V nodal and bundle branch conduction in the canine heart. Am. J. Cardiol. 31, 35–40 (1973)
Proctor, J.D., Allen, F.J., Wasserman, A.J.: Hemodynamic effects of alprenolol/H56/28/. Arch. Int. Pharmacodyn. Ther. 181, 363–377 (1969)
Raines, A., Moros, D., Levitt, B.: The effect of guanethidine on ouabain-induced ventricular arrhythmias in the cat. Arch. Int. Pharmacodyn. Ther. 174, 373–377 (1968)
Reissmann, K.R., Kapoor, S.: Dynamics of hypothermic heart muscle (heart-lung preparation). Am. J. Physiol. 184, 162–170 (1956)
Reuter, H.: Divalent cations as charge carriers in excitable membranes. Prog. Biophys. Mol. Biol. 26, 1–43 (1973)
Reuter, H.: Localization of beta-adrenergic receptors and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle. J. Physiol. 242, 429–451 (1974)
Richards, A.M., Jerde, O.M.: Bretylium tosylate and electroshock as combined therapy for intractable ventricular fibrillation and arrhythmias in myocardial infarction. Am. J. Cardiol. 23, 134 (1969)
Richardson, J.A., Woods. E.F., Bagwell, E.E.: Circulating epinephrine and norepinephrine in coronary occlusion. Am. J. Cardiol. 5, 613–621 (1960)
Roberts, J., Ito, R., Reilly, J., Cairoli, V.J.: Influence of reserpine and β-TMIO on digitalis-induced ventricular arrhythmia. Circ. Res. 13, 149–158 (1963)
Roberts, J., Kelliher, G.J., Lathers, C.M.: Role of adrenergic influences in digitalis-induced ventricular arrhythmias. Life Sci. 18, 665–677 (1976)
Robinson, G.A., Butcher, R.W., Sutherland, E.W.: Cyclic AMP. New York: Academic Press 1971
Romhilt, D.W., Fowler, N.O.: Bretylium tosylate. In: Current cardiovascular topics. Donoso, E. (ed.), Vol. I. Part 1, p. 80. 9. Stuttgart: Thieme 1975
Rosen, M.R., Gelband, H.: Antiarrhythmic drugs. Am Heart J. 81, 428–436 (1971)
Rosen, M.R., Gelband, H., Hoffman, B.F.: Electrophysiologic effects of phentolamine on canine Purkinje fibers. Am. J. Cardiol. 26, 657 (1970)
Rosen, M.R., Gelband, H., Hoffman, B.F.: Effects of phentolamine on electro-physiologic properties of isolated canine Purkinje fibers. J. Pharmacol. Exp. Ther. 179, 586–593 (1971)
Rosen, M.R., Hoffman, B.F., Wit, A.L.: Electrophysiology and pharmacology of cardiac arrhythmias V. Cardiac arrhythmic effects of lidocaine. Am. Heart J. 89, 526–536 (1975)
Rosen, M.R., Mary-Rabine, L., Hordof, A.J., Danilo, P. jr.: Alpha- and beta-adrenergic effects on cardiac automaticity. In: Neural mechanisms in cardiac arrhythmias. Schwartz, P.J., Brown, A.M., Malliani, A., Zanchetti, A. (eds.), pp. 365–375. New York: Raven Press 1978
Rothberger, C.J., Winterberg, H.: Über die Bezeichungen der Herznerven zur automatischen Reizerzeugung und zum plötzlichen Herztode. Pflügers Arch. ges. Physiol. 141, 343–377 (1911a)
Rothberger, C.J., Winterberg, H.: Über die experimentelle Erzeugung extrasystolischer ventrikulär Tachykardie durch Akzeleransreizung. Pflügers Arch. ges. Physiol. 142, 461–522 (1911b)
Rouse, W.: Effects of propranolol and ouabain on the conducting system of the heart in dogs. Am. J. Cardiol. 18, 406–413 (1966)
Rüssel, R.A., Crafoord, J., Harris, A.S.: Changes in myocardial composition after coronary artery ligation. Am. J. Physiol. 200, 995–998 (1961)
Sanna, G., Arcidiacono, R.: Chemical ventricular defibrillation of the human heart with bretylium tosylate. Am. J. Cardiol. 32, 982–987 (1973)
Scherlag, B.J., Hope, R.R., Williams, D.O., El-Sherif, N., Lazzara, R.: Mechanism of ectopic rhythm formation due to myocardial ischemia: effects of heart rate and ventricular premature beats. In: The conduction system of the heart. Wellens, H.J.J., Lie, K.I., Janse, M.J. (eds.), pp. 633 - 649. Leiden: Stenfert Croese, B.V. 1976
Schneider, F.H., Gillis, C.N.: Hypothermic potentiation of chronotropic response of isolated atria to sympathetic nerve stimulation. Am. J. Physiol. 211, 890–896 (1966)
Schöne, H.H., Lindner, E.: Die Wirkungen des N-[3’-phenyl-propyl-/2’I]-l,l-diphenyl-pro- pyl-/3/-amins auf den Stoffwechsel von Serotonin und Noradrenalin. Arzneim. Forsch. 10, 583–585 (1960)
Schwartz, P.J., Brown, A.M., Malliani, A., Zanchetti, A.: Neural mechanisms in cardiac ar-rhythmias. New York: Raven Press 1978
Seides, S.F., Josephson, M.E., Batsford, W.P., Weisfogel, G.M., Lau, S.H., Damato, A.N.: The electrophysiology of propranolol in man. Am. Heart J. 88, 733–741 (1974)
Sekiya, A., Vaughan Williams, E.M.C.: A comparison of the antifibrillatory actions and effects on intracellular cardiac potentials of pronethalol, disopyramide and quinidine. Br. J. Pharmacol. 21, 473–481 (1963 a)
Sekiya, A., Vaughan Williams, E.M.: The effects of pronethalol, dichloroisoproterenol and disopyramide on the toxicity to the heart of ouabain and anesthetics. Br. J. Pharmacol. 21, 462–472 (1963 b)
Shindler, R., Harakal, C., Levy, R.W.: Catecholamine content of sinoatrial node and right atrial tissue. Proc. Soc. Exp. Biol. Med. 128, 798–800 (1968)
Shumacker, H.B.J., Riberi, A., Bone, R.D., Kajikuri, H.: Ventricular fibrillation in the hypothermic state: IV. The role of extrinsic cardiac innervation. Ann. Surg. 143, 223–230 (1956)
Singh, B.N.: Antiarrhythmic effects of local anaesthetics and calcium antagonists. Pharmacol. Ther. [C] 2, 125–150 (1977 a)
Singh, B.N.: Side effects of antiarrhythmic drugs. Pharmacol. Ther. [B] 2, 151–166 (1977b)
Smirnov, A.I., Belyavskaya, L.A., Kovanova, T.W.: On the influence of extra-cardiac nerves on the functional state of the cardiovascular system under general hypothermia. Bull. Exp. Biol. Med. 65, 3134 (1968)
Smithen, C.S., Balcon, R., Sowton, E.: Use of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br. Heart J. 33, 955–961 (1971)
Sodermark, T., Jonsson, B., Olsson, A.: Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. Br. Heart J. 37, 486–492 (1975)
Sodhi, H.K., Booker, W.M., Bhagat, B.: The effect of mephentermine on digitalis-induced arrhythmias. Arch. Int. Pharmacodyn. Ther. 161, 132–137 (1966)
Somani, P., Lum, B.K.B.: The antiarrhythmic actions of beta adrenergic agents. J. Pharmacol. Exp. Ther. 147, 194–204 (1965)
Somani, P., Lum, B.K.B.: Blockade of epinephrine- and ouabain-induced cardiac arrhythmias in the dog heart-lung preparation. J. Pharmacol. Exp. Ther. 152, 235–242 (1966)
Sowton, E., Burkart, F.: Hemodynamic changes after beta adrenergic blockade. Am. J. Cardiol. 18, 317–320 (1966)
Staszewska-Barczak, J., Ceremuzynski, L.: The continuous estimation of catecholamine release in the early stages of myocardial infarction in the dog. Clin. Sci. 34, 513–519 (1968)
Steffen, V., Fiehring, H.: Bretylium tosylat als Antiarrhythmikum. Z. Inn. Med. 31, 913–919 (1976)
Stern, S., Eisenberg, S.: The effect of propranold (Inderal) on the electrocardiogram of normal subjects. Am. Heart J. 77, 192–195 (1969)
Stewart, G.R., Lynch, P.R., Barrera, F., Oppenheimer, M.J.: Changes in properties of heart muscle due to mephentermine. Am. J. Physiol. 186, 513–517 (1956)
Stone, C.A., Porter, C.C.: Biochemistry and pharmacology of methyldopa and some related structures. Adv. Drug Res. 4, 71 (1967)
Strauss, H.C., Bigger, J.T. jr., Hoffman, B.F.: Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ. Res. 26, 661–678 (1970)
Stutzman, J.W., Pettinga, F.L., Fruggiero, E.J.: Cardiac effects of methocamine (B-)2,5-di- methoxy-phenyl(-α-hydroxyisopropyl amine HCl) and desoxyephedrine during cyclopropane anesthesia. J. Pharmacol. Exp. Ther. 97, 385–387 (1949)
Szekeres, L.: Einfluß von Hypoxie auf die Vagus und Acetylcholin-Empfindlichkeit des Säugetierherzens. Acta Physiol. Acad. Sci. Hung. 6, 109 (1954)
Szekeres, L.: Wirkung von Pharmaka auf die Erregungsleitung am hypoxischen Herzen. Naunyn-Schmiedeberg’s Arch. exp. Pathol. Pharmakol. 233, 338–342 (1958)
Szekeres, L.: Discussion of Dr. West’s paper. Pharmacology of cardiac function. Proc. of the 2nd International Pharmacological Meeting, Prague, Vol. 5, pp. 143–148. Oxford: Pergamon Press 1964 a
Szekeres, L.: Auswertung von flimmerwidrigen Substanzen. II. Conferentia Hungarica pro Therapia et Investigations in pharmacologia, Budapest pp. 163–169, 1964 b
Szekeres, L.: Pharmacological and other factors influencing heart rhythm disturbances. Thesis, Pécs 1965
Szekeres, L.: L’effet antiarrhythmique. Actualités Pharmacologiques XIX Serie, pp. 149–186. Paris: Masson et Cie. 1966
Szekeres, L.: Methods for evaluating antiarrhythmic agents. In: Methods in pharmacology. Schwartz, A. (ed.), Vol. 1, pp. 151–190. New York: Appleton-Century-Crofts 1971
Szekeres, L.: Factors promoting the appearance of arrhythmias after coronary occlusion. In: Symposium on drugs and heart metabolism. Szekeres, L., Papp, J.Gy. (eds.), pp. 112–115. Budapest: Akadémiai Kiadô 1973
Szekeres, L.: Pharmacological principles of the therapy of early postinfarction arrhythmias. In: Herzinfarkt. Schettler, G., Horsch, A., Möer, H., Weivel, A., Orth, H. (eds.), pp. 216–229. Stuttgart, New York: Schattauer 1977
Szekeres, L.: A myocardiâlis infarctusban kialakulô arrhythmiâk elektrofiziolôgiâja. (Electrophysiology of arrhythmias appearing in myocardial infarction). In: Myocardialis infarctus. Antalôczy, Z., Kârpâti, P. (eds.), pp. 348–393. Budapest: Medicina 1978 a
Szekeres, L.: Theoretical considerations concerning drug treatment of dysrhythmias due to coronary insufficiency. In: Advances in pharmacology and therapeutics. Duchêne-Marullaz, P. (ed.), p. 257–275, Vol. 6. Oxford, New York: Pergamon Press 1978 b
Szekeres, L., Lénârd, G.: Über die Wirkung der Vasodilatatoren auf die Kranzgefäße in der Hypothermie. Acta Physiol. Acad. Sci. Hung. 16, Suppl., 87–88 (1959)
Szekeres, L., Papp, J.Gy.: Uber Regulation der Flimmerbereitschaft des Herzens in Hypoxie. Naunyn-Schmiedeberg’s Arch. exp. Pathol. Pharmakol. 245, (1963)
Szekeres, L., Papp, J.Gy.: The influence of the autonomic nervous system on the mammalian heart’s tendency to fibrillation. Acta Physiol. Acad. Sci. Hung. 24, Suppl., 38 (1964)
Szekeres, L., Papp, J.Gy.: Role of adrenergic mechanism in the mode of action of antianginal drugs. Acta Physiol. Acad. Sci. Hung. 30, 334–335 (1966)
Szekeres, L., Papp, J.Gy.: Effect of arterial hypoxia on the susceptibility to arrhythmias of the heart. Acta Physiol. Acad. Sci. Hung. 32, 143 (1967)
Szekeres, L., Papp, J.Gy.: Antiarrhythmic compounds. In: Progress in drug research. Jucker, E. (ed.), Vol. 12, pp. 292–369. Basel, Stuttgart: Birkhäuser 1968
Szekeres, L., Papp, J.Gy.: Experimental cardiac arrhythmias and antiarrhythmic drugs. A monograph. Budapest: Akadémiai Kiadô 1971
Szekeres, L., Vaughan Williams, E.M.: Antifibrillatory action. J. Physiol. (Lond.) 160, 470–482 (1962)
Szekeres, L., Faller, J., Lichner, G.: Empfindlichkeit der einzelnen Reizbildungszentren des Herzens gegenüber Kohlensäure und Hypoxie. Naunyn-Schmiedeberg’s Arch. exp. Pathol. Pharmacol. 233, 343–347 (1958)
Szekeres, L., Méhes, J., Papp, J.Gy.: Mechanism of increased susceptibility to fibrillation of the hypothermic mammalian heart in situ. Br. J. Pharmacol. 17, 167–175 (1961)
Szekeres, L., Papp, J.Gy., Förster, W.: The action of adrenergic-receptor blocking agents on susceptibility to cardiac arrhythmias in hypothermia and hypoxia. Experientia 21, 720–724 (1965)
Szekeres, L., Papp, J.Gy., Förster, W.: Effect of sympatholytic drugs blocking beta receptors on cardiac arrhythmia in hypoxia and hypothermia. Acta Physiol. Acad. Sci. Hung. 29, 444 (1966)
Szekeres, L., Papp, J.Gy., Fischer, E.: The possible role of an adrenergic mechanism in the mode of action of antianginal drugs. Eur. J. Pharmacol. 2, 1–8 (1967 a)
Szekeres, L., Papp, J.Gy., Förster, W.: Uber die Wirkung beta-Rezeptoren blockierenden Sympatholytika auf die Arrhythmiebereitschaft des Herzens in Hypoxie und Hypothermie. In: Verhandlungen der Gesellschaft für experimentelle Medizin der Deutschen Demokratischen Republik, Vol. 12, p. 243. Dresden: Steinkopf 1967 b
Szekeres, L., Papp, J.Gy., Udvary, É.: Early electrophysiological changes in the non-infareted myocardium and their relations to arrhythmias appearing soon after coronary occlusion. Revista Espanola de Cardiologia VI. Congreso Europeo de Cardiologia. Symposia, Mesas Redondas y Communicaciones, Madrid 1972 a Communie. A/3
Szekeres, L., Papp, J.Gy., Udvary, É.: Pharmacological interventions against arrhythmias appearing after coronary occlusion. Proceedings of the 5 th International Congress on Pharmacology, San Francisco 1972 b, p. 227
Szekeres, L., Udvary, É., Papp, J.Gy.: The role of non-ischemic myocardial areas in the genesis of arrhythmias occuring after coronary occlusion. Acta Physiol. Acad. Sci. Hung. 41, 340 (1972 c)
Szekeres, L., Takàts, I., Udvary, É.: Early metabolic changes in the non-infarcted myocardium after coronary occlusion. In: Proceedings of the Symposium of the International Study Group for Research in Cardiac Metabolism., Prague, 1974. p. 24
Szekeres, L., Csik, V., Udvary, É.: Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris. J. Pharmacol. Exp. Ther. 196, 15–28 (1976 a)
Szekeres, L., Csordàs-Nagy, É., Udvary, É.: Role of the ischaemic focus as well as that of the noninfarcted myocardium in the genesis and pharmacotherapy of ventricular arrhythmias appearing soon after coronary occlusion. In: Symposium on pharmacology of the heart. Szekeres, L., Papp, J.Gy. (eds.), pp. 29–37. Budapest: Akadémiai Kiadó 1976 b
Szekeres, Zs., Németh, M., Papp, J.Gy.: Sensitivity to serotonin in the developing heart. Lecture held on the 3rd Congress of the Hungarian Pharmacological Society, Debrecen 1977, p. 55
Szekeres, Zs., Németh, M., Papp, J.Gy., Szekeres, L.: Effects of serotonin on the heart. Acta Physiol. Acad. Sci. Hung. 51, 194 (1978)
Szigoleit, W., Förster, W.: Einfluß von Dichlorisoproterenol (DCI) auf die Infusionstoxizität einiger Herzglykoside. Experientia 20, 229–230 (1964)
Takàts, I., Udvary, Èva, Szekeres, L.: Effect of coronary occlusion on the phosphate esters in the myocardial areas unaffected by ligation. Acta Physiol. Acad. Sci. Hung. 41, 341 (1972)
Takàts, I., Vaghy, P., Szekeres, L.: Comparative study on ischemic heart models used for analyzing the effects of antianginal drugs on cardiac metabolism. Acta Physiol. Acad. Sci. Hung., 44, 410 (1973)
Takàts, I., Szekeres, L., Udvary, Èva: Influence of pharmacological interventions aimed at reducing extrasystolic activity after coronary occlusion on early metabolic changes appearing in the non-infarcted myocardium. Naunyn-Schmiedeberg’s Arch. Pharmacol. 285, R81 (1974)
Takàts, I., Vaghy, P., Csete, K., Szekeres, L.: High-energy phosphate level of the non-ischemic myocardium shortly after coronary occlusion. Acta Physiol. Acad. Sci. Hung., 47, 258 (1976 a)
Takàts, I., Szekeres, L., Udvary, É.: Development and pharmacological influence of metabolic changes appearing soon after coronary occlusion in the non-infarcted myocardium. In: Symposium on pharmacology of the heart. Szekeres, L., Papp, J.Gy. (eds.), pp. 247–253. Budapest: Akadémiai Kiadó 1976 b
Tardos, L., Lendvai, J., Leszkovszky, G.: Structure-activity relationship in the antiarrhythmic and coronary dilator actions of diphenylalkylamine derivatives. Proceedings of the IV th Hungarian Conference for Therapy and Pharmacological Research, p. 225. Budapest: Akadémiai Kiadó 1968
Taylor, D.A., Westfall, D.P., Moraes, S., Fleming, W.W.: The effect of pretreatment with reserpine on the diastolic potential of guinea-pig atrial cells. Naunyn-Schmiedeberg’s Arch. Pharmacol. 293, 81–87 (1976)
Terry, G., Vellani, C.W., Higgins, M.R., Doig, A.: Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction. Br. Heart J. 32, 21–25 (1970)
Thaemert, J.C.: Atrioventricular node innervation in ultrastructural three dimensions. Am. J. Anat. 128, 239–263 (1970)
Toda, N.: Effects of adrenaline, noradrenaline and reserpine on the transmembrane potentials in both pacemakers and non-pacemaker fibers of the rabbit atrium. Jpn. J. Pharmacol. 10, 78–91 (1960)
Tournade, A., Hamet, R.: Syncope noradrénalinochloroformique. C.R. Soc. Biol. (Paris) 111, 897–900 (1932)
Tranzer, J.P., Thoenen, H.: An electron microscopic study of selective acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia 24, 155–156 (1968)
Trautwein, W.: Generation and conduction of impulses in the heart as affected by drugs. Pharmacol. Rev. 15, 277–332 (1963)
Tse, W.W., Davis, L.D.: Effects of epinephrine on the diastolic depolarization of the canine AV node. Fed. Proc. 31, 556 (1972)
Tsien, R.W.: Effects of epinephrine on the pacemaker potassium current of cardiac Purkinje fibers. J. Gen. Physiol. 64, 293–319 (1974)
Tsien, R.W.: Mode of action of chronotropic agents in cardiac Purkinje fibers. Does epinephrine act by directly modifying the external surface charge ? J. Gen. Physiol. 64, 320–342 (1974)
Tuganowski, W.: The influence of adenylate cyclase inhibitors on the spontaneous activity of the cardiac pacemaker. Arch. Int. Pharmacodyn. Ther. 225, 275–286 (1977)
Tuganowski, W., Kopec’, P., Kopyta, M., Wezowska, J.: Iontophoretic application of autonomic mediators and cyclic nucleotides in the sinus node cells. Naunyn-Schmiedeberg’s Arch. Pharmacol. 299, 65–67 (1977)
Udvary, E., Csik, V., Szekeres, L.: Changes after coronary ligation in the electrophysiological parameters of myocardial regions not directly affected by the ligature. Acta Physiol. Acad. Sci. Hung. 44, 419 (1973)
Valori, C., Thomas, M., Shillingford, J.: Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am. J. Cardiol. 20, 605–617 (1967)
Van Dongen, K.: The action of (para)sympatol on fibrillation of the heart. Arch. Int. Pharmacodyn. Ther. 62, 261–263 (1939)
Vargaftig, B., Coignet, J.L.: A critical evaluation of three methods fot the study of adrenergic beta blocking and antiarrhythmic agent. Eur. J. Pharmacol. 6, 49–55 (1969)
Vargas, G., Akhtar, M., Damato, A.N.: Electrophysiologic effects of isoproterenol on cardiac conduction system in man. Am. Heart J. 90, 25–34 (1975)
Varma, D.R., Gillis, R.A., Melville, K.F.: On the relationship of catecholamines and thyroid activity to ventricular fibrillation during hypothermia in dogs. Can. J. Biochem. 41, 361–367 (1963)
Varró, A., Borbola, J., Papp, J.Gy., Szekeres, L.: Effect of biogenic amines on the automaticity of the isolated heart. Acta Physiol. Acad. Sci. Hung. 51, 215 (1978)
Vassalle, M., Barnabei, O.: Norepinephrine and potassium fluxes in cardiac Purkinje fibers. Pflügers Arch. 322, 287–303 (1971)
Vassalle, M., Greenspan, K., Hoffman, F.B.: An analysis of arrhythmias induced by ouabain in intact dogs. Circ. Res. 13, 132–148 (1963)
Vassalle, M., Levine, M.J., Stuckey, J.H.: On the sympathetic control of ventricular automaticity. The effects of stellate ganglion stimulation. Circ. Res. 23, 249–258 (1968)
Vassalle, M., Stuckey, J.H., Levine, M.: Sympathetic control of ventricular automaticity: Role of adrenal medulla. Am. J. Physiol. 217, 930–939 (1969)
Vassort, G., Rougier, O., Garnier, D., Sauriat, M.P., Coraboeuf. E., Garguil, Y.M.: Effects of adrenaline on membrane inward currents during action potential. Pflügers Arch. 309, 70–81 (1969)
Vaughan Williams, E.M.: Some observations concerning the mode of action of acetylcholine in isolated rabbit atria. J. Physiol. (Lond.) 140, 327–346 (1958)
Vaughan Williams, E.M.: Classification of antidysrhythmic drugs. Pharmacol. Ther. [B] 1, 115–138 (1975)
Vaughan Williams, E.M., Papp, J.Gy.: The effect of oxprenolol on cardiac intracellular potentials in relation to its antiarrhythmic, local anaesthetic and other properties. Postgrad. Med. J. 46, 22–32 (1970)
Vincent, G.M., Abildskov, J.A., Burgers, M.J.: Q-T interval syndromes. Prog. Cardiovasc. Dis. 16, 523–530 (1974)
Wallace, A.G., Sarnoff, S.J.: Effects of cardiac sympathetic nerve stimulation on conduction in the heart. Circ. Res. 14, 86–92 (1964)
Wallace, A.G., Troyer, W.G., Lesage, M.A., Zotti, E.F.: Electrophysiologic effects of isoproterenol and beta blocking agents in awake dogs. Circ. Res. 18, 140–148 (1966)
Wallace, A.G., Schaal, S.F., Sugimoto, T., Rozear, M., Alexander, J.A.: The electrophysiologic effects of beta-adrenergic blockade and cardiac denervation. Bull. N.A. Acad. Med. 43, 119–124 (1967)
Wasserman, A.J., Proctor, J.D., Allen, F J., Kemp, V.E.: Human cardiovascular effects of alprenolol, a beta adrenergic blocker; Hemodynamic antiarrhythmic and antianginal. J. Clin. Pharmacol. 10, 37–49 (1970)
Waud, D.R., Kottegoda, S.R., Krayer, O.: Threshold dose and time course of norepinephrine depletion of the mammalian heart by reserpine. J. Pharmacol. Exp. Ther. 124, 340–346 (1958)
Wellens, D., Wauters, A.: Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog. Arch. Int. Pharmacodyn. Ther. 198, 355–371 (1972)
West, T.C.: Electrophysiology of the sinoatrial node. In: Electrical phenomena in the heart. De Mello, W.C. (ed.), p. 191. New York, London: Academic Press 1972
West, T.C., Falk, F., Cervoni, P.: Drug alteration of transmembrane potentials in atrial pacemaker cells. J. Pharmacol. Exp. Ther. 117, 245–257 (1956)
Wilburne, M., Surtshin, A., Rodband, S., Katz, L.N.: Inhibition of paroxismal ventricular tachycardia by atropine. Am. Heart J. 34, 860–870 (1947)
Williams, B.J., Griffith, W.H., Albrecht, C.M.: The protective effect of phentolamine against cardiac arrhythmias in the rat. Eur. J. Pharmacol. 49, 7–14 (1978)
Wit, A.L., Bassett, A.L.: Electrical and mechanical effects of alprenolol on isolated heart muscle. Fed. Proc. 30, 393 (1971)
Wit, A.L., Bigger, J.T.: Possible electrophysiological mechanism for lethal arrhythmias accompanying myocardial ischaemia and infarction. Circulation 56, Suppl. III, 96–108 (1977)
Wit, A.L., Friedman, P.L.: Basis for ventricular arrhythmias accompanying myocardial infarction. Arch. Intern. Med. 135, 459–472 (1975)
Wit, A.L., Steiner, C., Damato, A.N.: Electrophysiological effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle. J. Pharmacol. Exp. Ther. 173, 344–356 (1970)
Wit, A.L., Rosen, M.R., Hoffman, B.F.: Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias. A. Automaticity. Am. Heart J. 88, 515–524 (1974)
Wit, A.L., Hoffman, B.F., Rosen, M.R.: Electrophysiology and pharmacology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A. Am. Heart J. 90, 521–533 (1975 a)
Wit, A.L., Hoffman, B.F., Rosen, M.R.: Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptors stimulation and blockade. Part B. Am. Heart J. 90, 665–675 (1975 b)
Wit, A.L., Hoffman, B.F., Rosen, M.R.: Electrophysiology and pharmacology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part C. Am. Heart J. 90, 795–803 (1975 c)
Wollenberger, A., Shahab, L.: Anoxia induced release of noradrenaline from the isolated perfused heart. Nature 207, 88–89 (1965)
Wollemann, M., Borbola, J., Papp, J.Gy., Szekeres, L.: Cardiac adenylate cyclase activity in relation to beta-adrenergic responses. J. Mol. Cell. Cardiol. 7, 523–533 (1975)
Wu, C.H., Narahashi, T.: Mechanism of action of propranolol on squid axon membranes. J. Pharmacol. Exp. Ther. 184, 155–162 (1973)
Yamasaki, Y., Fujiwara, M., Toda, N.: Effects of intracellulary applied cyclic 3’-5’-adenosine monophosphate and dibutyryl cyclic 3’,5’-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit. J. Pharmacol. Exp. Ther. 190, 15–20 (1974)
Yanowitz, F., Preston, J.B., Abildskov, J.A.: Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ. Res. 18, 416–428 (1966)
Zao, Z.Z.: Studies on the nature of the S-T segment changes influenced by varying concentrations of oxygen in experimental coronary artery occlusion in the dog. Am. Heart J. 58, 88–93 (1959)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Szekeres, L., Papp, J.G. (1980). Effect of Adrenergic Activators and Inhibitors on the Electrical Activity of the Heart. In: Szekeres, L. (eds) Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology, vol 54 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67505-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-67505-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67507-2
Online ISBN: 978-3-642-67505-8
eBook Packages: Springer Book Archive